Glicia de Albuquerque
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Glicia de Albuquerque has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Alessandro Vidal de Oliveira
Universidade do Estado do Pará, Brazil
1 shared publication - Ana Luiza Nepomuceno Sampaio
Universidade do Estado do Pará, Brazil
1 shared publication - Camila Lima Soares
Universidade do Estado do Pará
1 shared publication - Dangilla Ribeiro dos Santos
Department of Medicine University of Pará State Belém Pará Brazil
1 shared publication - Elionai Felipe Rocha de Lima Souza
Universidade do Estado do Pará
1 shared publication - Higson Rodrigues Coelho
Universidade do Estado do Pará
1 shared publication
Latest Publications
- Open Access
- 19 May 2026
- Published by Universidade do Estado do Pará – Campus IX – Altamira in Revista de Educação, Saúde e Ciências do Xingu
- Vol. 1 (9) , 29
SAÚDE MENTAL E UNIVERSITÁRIOS: IDENTIFICAÇÃO DE FATORES RELACIONADOS AO ADOECIMENTO PSÍQUICO DE ESTUDANTES UNIVERSITÁRIOS DA ÁREA DA SAÚDE
University life in the health field poses challenges that impact students’ mental health. This qualitative integrative review aimed to identify risk factors associated with psychological distress among health sciences undergraduates between 2019 and 2024. The methodology was based on the PICo strategy for formulating the guiding question, and the search was conducted in the LILACS, MEDLINE, PubMed, BDENF, and SciELO databases using the descriptors “Mental Health,” “Health Sciences Students,” and “Risk Factors.” Twelve studies were included, indicating excessive academic workload, performance pressure, and sleep deprivation as the main triggers of stress, anxiety, and depression in the target population. Socioeconomic difficulties, low income, and lack of social support increased vulnerability, particularly among scholarship students. Women showed a higher prevalence of psychological distress. Unhealthy lifestyle habits, such as physical inactivity, poor diet, and alcohol and drug use, worsened mental health c
- 19 May 2026
- Published by Universidade do Estado do Pará – Campus IX – Altamira in Revista de Educação, Saúde e Ciências do Xingu
- Vol. 1 (9) , 29
Open AccessSAÚDE MENTAL E UNIVERSITÁRIOS: IDENTIFICAÇÃO DE FATORES RELACIONADOS AO ADOECIMENTO PSÍQUICO DE ESTUDANTES UNIVERSITÁRIOS DA ÁREA DA SAÚDE
University life in the health field poses challenges that impact students’ mental health. This qualitative integrative review aimed to identify risk factors associated with psychological distress among health sciences undergraduates between 2019 and 2024. The methodology was based on the PICo strategy for formulating the guiding question, and the search was conducted in the LILACS, MEDLINE, PubMed, BDENF, and SciELO databases using the descriptors “Mental Health,” “Health Sciences Students,” and “Risk Factors.” Twelve studies were included, indicating excessive academic workload, performance pressure, and sleep deprivation as the main triggers of stress, anxiety, and depression in the target population. Socioeconomic difficulties, low income, and lack of social support increased vulnerability, particularly among scholarship students. Women showed a higher prevalence of psychological distress. Unhealthy lifestyle habits, such as physical inactivity, poor diet, and alcohol and drug use, worsened mental health c
- 5 November 2025
- Published by Wiley in The Prostate
- Vol. 86 (3) , 279-290
Tranexamic Acid in Men Undergoing Transurethral Resection of Prostate: An Updated Systematic Review and Meta‐Analysis
Background: Prostatic tissue is richly vascularized by large venous sinuses that may rupture during transurethral resection of the prostate (TURP), which may lead to unwanted functional outcomes and intraoperative bleeding. However, tranexamic acid (TXA) may be a valid strategy to reduce bleeding complications. Thus, we aimed to analyze the efficacy and safety of TXA administration in patients undergoing TURP. Methods: We systematically reviewed the Medline, Embase, CENTRAL, and clinical trials registry platforms from their inceptions through April 2025 for randomized and quasi‐randomized controlled trials with patients undergoing TURP that compared TXA versus placebo or no treatment. A pairwise meta‐analysis with random‐effects was performed to estimate risk ratios (RR), mean differences (MD) and their 95% confidence intervals (CI). Results: A total of 13 studies ( N = 1140) were included in our synthesis. We found that patients using TXA (mean: 1.20 g/dL) compared to control (mean: 1.79 g/dL) had less reduction in postoperative hemoglobin concentration (MD: −0.58 g/dL, CI −0.95–[−0.22]). Additionally, patients using TXA (mean: 162.3 mL) compared to control (mean: 231.1 mL) had fewer intraoperative blood loss (MD: −68.7 mL, CI −128.73–[−8.67]). We did not find differences between TXA and control when analyzing risk of blood transfusion (RR: 0.71, CI 0.46–1.10), length of stay (MD: −1.50, CI −6.91–3.92), operative time (MD: −9.34, CI −19.40–0.72), or risk of thromboembolic events (RR: 1.15, CI 0.89–1.49). There were, however, differences in intervention protocols and the number of participants in each study, in addition to high heterogeneity in some endpoints. Conclusion: TXA is associated with lower intraoperative blood loss and higher postoperative hemoglobin concentrations without increasing the risk of thromboembolic events, indicating a valid prophylaxis before TURP. However, further studies should better address the blood transfusion risk and be adequately powered for that purpose.
- 5 November 2025
- Published by Wiley in The Prostate
- Vol. 86 (3) , 279-290
Tranexamic Acid in Men Undergoing Transurethral Resection of Prostate: An Updated Systematic Review and Meta‐Analysis
Background: Prostatic tissue is richly vascularized by large venous sinuses that may rupture during transurethral resection of the prostate (TURP), which may lead to unwanted functional outcomes and intraoperative bleeding. However, tranexamic acid (TXA) may be a valid strategy to reduce bleeding complications. Thus, we aimed to analyze the efficacy and safety of TXA administration in patients undergoing TURP. Methods: We systematically reviewed the Medline, Embase, CENTRAL, and clinical trials registry platforms from their inceptions through April 2025 for randomized and quasi‐randomized controlled trials with patients undergoing TURP that compared TXA versus placebo or no treatment. A pairwise meta‐analysis with random‐effects was performed to estimate risk ratios (RR), mean differences (MD) and their 95% confidence intervals (CI). Results: A total of 13 studies ( N = 1140) were included in our synthesis. We found that patients using TXA (mean: 1.20 g/dL) compared to control (mean: 1.79 g/dL) had less reduction in postoperative hemoglobin concentration (MD: −0.58 g/dL, CI −0.95–[−0.22]). Additionally, patients using TXA (mean: 162.3 mL) compared to control (mean: 231.1 mL) had fewer intraoperative blood loss (MD: −68.7 mL, CI −128.73–[−8.67]). We did not find differences between TXA and control when analyzing risk of blood transfusion (RR: 0.71, CI 0.46–1.10), length of stay (MD: −1.50, CI −6.91–3.92), operative time (MD: −9.34, CI −19.40–0.72), or risk of thromboembolic events (RR: 1.15, CI 0.89–1.49). There were, however, differences in intervention protocols and the number of participants in each study, in addition to high heterogeneity in some endpoints. Conclusion: TXA is associated with lower intraoperative blood loss and higher postoperative hemoglobin concentrations without increasing the risk of thromboembolic events, indicating a valid prophylaxis before TURP. However, further studies should better address the blood transfusion risk and be adequately powered for that purpose.